Myriad Genetics and agency partner S50 Health educated OBGYNs and their patients in a campaign called “Getting Ahead of ...

SALT LAKE CITY - Myriad Genetics , Inc. (NASDAQ: NASDAQ:MYGN) announced today a collaboration with Flatiron Health to integrate its MyRisk Hereditary Cancer Test into Flatiron's OncoEMR platform.

MyRisk is the first hereditary cancer ... President and Chief Clinical Officer of Oncology, Myriad Genetics. “By making germline testing interoperable with OncoEMR, we aim to simplify the ...

Myriad’s MyRisk ® test is the first hereditary cancer test integrated into Flatiron’s OncoEMR ® SALT LAKE CITY, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a ...

SALT LAKE CITY - Myriad Genetics , Inc. (NASDAQ: NASDAQ:MYGN) announced today a collaboration with Flatiron Health to integrate its MyRisk Hereditary Cancer Test into Flatiron's OncoEMR platform. This ...

Most at-home DNA testing kits use saliva and provide a collection kit. Once you send your collection kit back to the company, they will likely either send it to a third-party lab or their own lab ...

MyRisk. With the development of RiskScore, Myriad Genetics has developed the only genetic test that combines the assessment for hereditary cancer risk with the genomic breast cancer risk ...

The firms said that the deal will provide access to Tempus' testing menu for healthcare providers at 800 cancer care locations that use Flatiron's OncoEMR platform.

Testing your DNA is easier than ever with an abundance of at-home DNA tests on the market. All you need to do is provide a simple DNA sample to learn more about your heritage and family history.

The recent publications containing data on tens of thousands of genetic tests performed on individuals of Ashkenazi Jewish descent reflect the arrival of a new era of genetic testing and awareness.

Opinions expressed by Forbes Contributors are their own. Ellen Matloff covers genetic counseling, testing and digital health. As a certified genetic counselor, one of the most common questions I ...